| Ident. | Authors (with country if any) | Title |
|---|
| 000042 (2007) |
Norihiro Nishimoto [Japon] ; Jun Hashimoto ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Norikazu Murata ; Désirée Van Der Heijde ; Tadamitsu Kishimoto | Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. |
| 000110 (2009) |
Norihiro Nishimoto [Japon] ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Junichi Azuma ; Tadamitsu Kishimoto | Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. |
| 000132 (2009) |
Hideto Kameda ; Tsutomu Takeuchi | [Rheumatoid arthritis]. |
| 000149 (2009) |
Jun Hashimoto [Japon] ; Patrick Garnero ; Désirée Van Der Heijde ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Hideki Yoshikawa ; Norihiro Nishimoto | A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs. |
| 000152 (2009) |
Tsutomu Takeuchi | [Present status and problems in biologics for treatment of rheumatoid arthritis in Japan]. |
| 000254 (2010) |
Jun Hashimoto [Japon] ; Patrick Garnero [France] ; Désirée Van Der Heijde [Pays-Bas] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Hideki Yoshikawa [Japon] ; Norihiro Nishimoto [Japon] | Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study |
| 000292 (2010) |
Tsutomu Takeuchi [Japon] ; Hideto Kameda | The Japanese experience with biologic therapies for rheumatoid arthritis. |
| 000300 (2011) |
Hisashi Yamanaka [Japon] ; Yoshiya Tanaka ; Eisuke Inoue ; Daisuke Hoshi ; Shigeki Momohara ; Kentaro Hanami ; Naoki Yunoue ; Kazuyoshi Saito ; Kouichi Amano ; Hideto Kameda ; Tsutomu Takeuchi | Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study). |
| 000352 (2011) |
Hideto Kameda [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Shunsuke Mori ; Yuji Yoshida ; Noboru Takayanagi ; Hirofumi Taki ; Yoshinori Hasegawa ; Kazuhiro Hatta ; Hisashi Yamanaka ; Makoto Dohi ; Shu Hashimoto ; Hidehiro Yamada ; Shinichi Kawai ; Tsutomu Takeuchi ; Kazuhiro Tateda ; Hajime Goto | Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study. |
| 000353 (2011) |
Takao Koike [Japon] ; Masayoshi Harigai [Japon] ; Shigeko Inokuma [Japon] ; Naoki Ishiguro [Japon] ; Junnosuke Ryu [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Hisashi Yamanaka [Japon] ; Koichi Fujii [Japon] ; Takunari Yoshinaga [Japon] ; Bruce Freundlich [États-Unis] ; Michio Suzukawa [Japon] | Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis |
| 000415 (2011) |
Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka ; Koichi Amano ; Daisuke Hoshi ; Masao Nawata ; Hayato Nagasawa ; Eri Sato ; Kazuyoshi Saito ; Yuko Kaneko ; Shunsuke Fukuyo ; Takahiko Kurasawa ; Kentaro Hanami ; Hideto Kameda ; Hisashi Yamanaka | Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study. |
| 000437 (2011) |
Takao Koike [Japon] ; Masayoshi Harigai ; Shigeko Inokuma ; Naoki Ishiguro ; Junnosuke Ryu ; Tsutomu Takeuchi ; Syuji Takei ; Yoshiya Tanaka ; Kyoko Ito ; Hisashi Yamanaka | Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients. |
| 000517 (2012) |
Ryota Sakai [Japon] ; Hayato Nagasawa ; Eiko Nishi ; Ayumi Okuyama ; Hirofumi Takei ; Takahiko Kurasawa ; Tsuneo Kondo ; Koji Nishimura ; Yuichiro Shirai ; Tatsuya Ito ; Hideto Kameda ; Tsutomu Takeuchi ; Koichi Amano | Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review. |
| 000938 (2014) |
Takao Koike [Japon] ; Masayoshi Harigai ; Shigeko Inokuma ; Naoki Ishiguro ; Junnosuke Ryu ; Tsutomu Takeuchi ; Syuji Takei ; Yoshiya Tanaka ; Yoko Sano ; Hitomi Yaguramaki ; Hisashi Yamanaka | Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan. |
| 000951 (2014) |
Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi ; Koichi Amano ; Kazuyoshi Saito ; Kentaro Hanami ; Masao Nawata ; Shunsuke Fukuyo ; Hideto Kameda ; Yuko Kaneko ; Takahiko Kurasawa ; Hayato Nagasawa ; Daisuke Hoshi ; Eri Sato ; Hisashi Yamanaka | Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors. |
| 000956 (2014) |
Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro Takagi | Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study. |
| 000957 (2014) |
Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro Takagi | Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study. |
| 000975 (2014) |
Naoshi Nishina [Japon] ; Jun Kikuchi ; Misato Hashizume ; Keiko Yoshimoto ; Hideto Kameda ; Tsutomu Takeuchi | Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy. |
| 000A70 (2015) |
Keisuke Izumi [Japon] ; Yuko Kaneko ; Hidekata Yasuoka ; Noriyuki Seta ; Hideto Kameda ; Masataka Kuwana ; Tsutomu Takeuchi | Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52. |
| 000C57 (2015) |
Naoshi Nishina [Japon] ; Yuko Kaneko ; Hideto Kameda ; Tsutomu Takeuchi | The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study. |
| 000D12 (2015) |
Jun Kikuchi [Japon] ; Misato Hashizume [Japon] ; Yuko Kaneko [Japon] ; Keiko Yoshimoto [Japon] ; Naoshi Nishina [Japon] ; Tsutomu Takeuchi [Japon] | Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response. |
